2,153
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials

, , & ORCID Icon
Pages 1274-1283 | Received 23 May 2021, Accepted 21 Aug 2021, Published online: 13 Sep 2021

References

  • Bao MM, Zhu YT, Xu MH. 2020. Advances in the treatment of chronic urticaria with traditional Chinese medicine. New Chin Med. 52 (6):8–10.
  • Chen HX, Ma LL, Xiong X, Xu W, Fang YM. 2017. Correlation between five immune parameters and clinical severity of chronic urticaria. Chin J Lepr Skin Dis. 33 (1):34–36.
  • Cui L, Cui J, Ji XY. 2017. Analysis of curative effect and recurrence rate of yupingfeng granules and ebastine in treatment of wind heat invading phenotype mixture urticaria. China Foreign Med Treat. 36 (35):110–111,114.
  • Deng JP. 2019. Clinical effect of desloratadine combined with compound glycyrrhizin on chronic urticaria. Modern Health Maint. 13:112–113.
  • Duan YH. 2018. Effect of compound glycyrrhizin combined with desloratadine in the treatment of chronic urticaria. Health Guide. 17(22):371.
  • Fan C. 2017. Clinical observation of compound glycyrrhizin combined with desloratadine in the treatment of chronic urticaria. J Frontiers of Med. 7(12):11–12.
  • Gao YY, Chen LH, Zhang F, Yu J, Shi N, Chen SH. 2016. Literature analysis of adverse reactions caused by compound glycyrrhizin. China Pharm. 27:1932–1935.
  • Gou TT. 2019. Clinical efficacy observation of desloratadine dispersible tablets combined with compound glycyrrhizin capsule in the treatment of chronic urticaria. J Big Health. 5:154–155.
  • Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. 2005. Comparative study of the impact of chronic urticarial psoriasis and atopic dermatitis on the quality of life. Br J Dermatol. 152(2):289–295.
  • Hang Y. 2018. Compound glycyrrhizin capsules combined with desloratadine tablets in the treatment of 102 cases of chronic measles. Health Must-Read Mag. 26(18):16–17.
  • Hu JR. 2016. Research progress on pathogenesis of chronic urticarial. Chin J Med. 29(5):142–145.
  • Lai W, Xie XY, Gong ZJ, Ye ZZ. 2010. Urticaria: a comparison between European 2009 guidelines and 2006 guidelines. J Diagnostics Ther Derm-Venereol. 17:176–178.
  • Lang G, Wen HY, Mu LF, Song JC. 2019. Efficacy and safety of desloratadine in the treatment of urticaria: A Meta-analysis. J Clin Meta-Analysis. 34:752–758.
  • Li GB, Xue QD, Tang QP. 2015. Clinical observation of desloratadine combined with compound glycyrrhizin in the treatment of chronic urticaria. J Med Res. 44 (1):150–153.
  • Li RX, Zhu HL, Liang BH, Gong YQ, Xiao CQ, Li JY, Li YQ, Zhang XB. 2010. Peripheral blood lymphocyte subsets and il-15, il-21, IgE detection in patients with urticaria. Chin J Dermatol. 24(8):708–711.
  • Liang BH, Li RX, Lin LY, Li ZJ, Xiao CQ, Zhu HL. 2014. Changes of coagulation status, complement and inflammatory markers during the onset and remission of chronic urticarial. Chin J Dermatol. 47(1):30–32.
  • Lin ZF, He B, Xiong C. 2014. Efficacy of desloratadine tablets combined with pidomod dispersive tablets in the treatment of chronic urticaria and its effect on T cell subgroup. J Pract Med. 30(15):2490–2492.
  • Ma CH. 2014. Clinical epidemiology of chronic urticarial. Chin Practical Med. 9(29):233–234.
  • Mastrorilli C, Bernardini R, Liotti L, Franceschini F, Crisafulli G, Caimmi S, Bottau P, Mori F, Cardinale F, Saretta F, et al. 2019. Chronic urticaria and drug hypersensitivity in children. Ital J Pediatr. 90:101–125.
  • Maurer M, Magerl M, Metz M, Zuberbier T. 2013. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J Dtsch Dermatol Ges. 11(10):971–978.
  • Peng XG. 2019. Efficacy of compound glycyrrhizin combined with desloratadine in the treatment of chronic urticaria. J Spec Health. 8(21):92.
  • Qian WW. 2017. Clinical study of combination of desloratadine and compound glycyrrhizin in the treatment of chronic urticaria. J Clin Med. 4:13204–13205.
  • Sheng GH, Sun AM, Yin MD, Zhu JY. 2018. Clinical efficacy of desloratadine combined with compound glycyrrhizin on patients with chronic urticaria and its effect on immune function improvement. J anti-Infective Pharm. 15(9):1603–1605.
  • Su WX, Tang MH, Wang JJ, Wei YQ, Zhao Y, Ji J, Jiao QQ. 2020. Update of chronic autoimmune urticaria. Chin J Lepr Skin Dis. 36(6):374–377.
  • Sui YM, Chen GJ, Yang Y, Wang Y, Zhang Y. 2018. Progress of clinical diagnosis and treatment of chronic urticarial. J Clin Misdiagnosis Mistreat. 31(11):106–110.
  • Sun JW. 2016. Clinical effect analysis of desloratadine combined with compound glycyrrhizin in the treatment of chronic urticaria. World Latest Med Inform Dig. 16(35):33–34.
  • Wang DQ, Xu JH. 2017. Advances in the pathogenesis of chronic urticaria. Chin J Physicians. 19(1):25–28.
  • Wang HM, Li L. 2013. Efficacy observation of compound glycyrrhizin combined with desloratadine for the treatment of chronic urticaria. Chin Rem Clin. 13(S1):57–58.
  • Wang HY. 2016. Clinical efficacy analysis of compound glycyrrhizin combined with desloratadine in the treatment of chronic urticaria. Chin J Modern Drug Application. 10(4):184–185.
  • Wu J. 2017. Clinical study on the treatment of chronic idiopathic urticaria with compound glycyrrhizin and desloratadine. Modern Med Clinical Sci. 32(4):693–697.
  • Wu LH. 2018. Efficacy of ibastin on serum interleukin-25 and 33 levels in patients with chronic spontaneous urticaria. Chin Health Stand Manag. 9(8):57–59.
  • Ying MX, Shi L. 2017. Effects of compound glycyrrhizin on chronic urticaria and its effect on T cell subgroup, IgE and EOS in peripheral blood. Chin J Rural Med Pharm. 24(6):34–35.
  • Yuan R. 2018. Pathogenesis and treatment progress of chronic urticarial. World Latest Med Inf Dig. 18(32):40–41.
  • Zang YQ. 2017. Clinical observation of desloratadine combined with compound glycyrrhizin in the treatment of chronic urticaria. J Jilin Med. 38(2):366–367.
  • Zeng DW, Wu WJ, Huang BZ, Chen YF, Xie ZH. 2017. Feasibility analysis of compound glycyrrhizin assisted desloratadine in the treatment of chronic urticaria. Chin Mod Med. 24(20):39–41.
  • Zhang DH, Yang YF, Liu YY, Li YR, Guo MY. 2021. Retrospective analysis of clinical efficacy of glycyrrhiza jingfang decoction in the treatment of chronic urticaria. J Guangzhou University Tradit Chin Med. 38(5):930–933.
  • Zhang YQ. 2015. Efficacy observation of desloratadine combined with compound glycyrrhizin capsule in the treatment of chronic urticaria. Med Inform. 29(5):287–288.
  • Zhu YQ, Tang H, Wang DQ, Shen YY, Shao YX, Xu JH. 2017. Research progress of vitamin D and chronic urticaria. Int J Dermatol Venereol. 43(4):223–226.
  • Zhu ZH, Li J, Sheng GR. 2021. Effect of Yinlianqufeng decoction on chronic urticaria and the level of IgE and T cell subsets. J Pharm Pract. 39(1):82–85.